国际经济与贸易学院知识库

     2020年初新型冠状病毒的爆发，使得医药产业再度成为人们关注的焦点，而国际化发展作为医药产业发展水平更高层次的体现也成为重中之重。中国和印度是发展中国家中医药产业国际化水平较高的两个国家，但是在国际化发展的过程中又存在着较大的差异。

    所以本文从中国和印度两个国家为出发点，从两国医药产业国际化发展的现状、国际化历程以及国际竞争力三个方面进行对比分析两国的医药产业国际化发展过程中存在的差异，并通过进一步研究发现两国存在差异的因素主要分为内部和外部两个方面，最后在借鉴印度成功经验的基础上，对我国医药产业未来的国际化道路提出建议，促使中国的医药产业国际化水平得到进一步的提高。

At the beginning of 2020,the outbreak of novel coronavirus makes the pharmaceutical industry become the focus of people's attention again ,and the international development as the embodiment of ahigherlevel of the development of the pharmaceutical industry has become the top priority.China and India are two developing countries with a higher level differences in the process of internationalization development.

So this article from the two countries China and India as a starting point,from the two countries in the development of medicine industry internationalization present situation,the internationalization process and the international competitiveness,comparing the three aspects and concludes that there aredifferences between the two countries through the analysis of the internal and external influences factors,finally,in India,on the basis of successful experience for reference to our country medicine industry recommendations to future internationalization path, prompting China's pharmaceutical industry internationalization level.